TScan Therapeutics develops TCR-T (T-cell receptor-engineered T cell) therapy product candidates using a non-viral transposon/transposase platform to insert TCR genetic information into T cell genomes. The company operates an internal manufacturing facility for clinical manufacturing and relies on third-party CROs, clinical sites, and a global third-party manufacturer for non-viral vector and other components. Its product candidates are cell therapies intended for clinical trials, with manufacturing involving transposon, transposase, and T cell harvesting processes.
expected 2026-12-11
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-04 | 2025-12-31 | 0001193125-26-089884 | EDGAR | 109K words |
| 2025-03-05 | 2024-12-31 | 0000950170-25-033077 | EDGAR | 128K words |
| 2024-03-06 | 2023-12-31 | 0000950170-24-026875 | EDGAR | 115K words |
| 2023-03-08 | 2022-12-31 | 0000950170-23-006589 | EDGAR | 116K words |
| 2022-03-09 | 2021-12-31 | 0000950170-22-003175 | EDGAR | 115K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-11-12 | 2026-09-30 | 0001193125-26-456919 | EDGAR | 73K words |
| 2026-08-12 | 2026-06-30 | 0001193125-26-345749 | EDGAR | 72K words |
| 2025-11-12 | 2025-09-30 | 0001193125-25-275933 | EDGAR | 71K words |
| 2025-08-12 | 2025-06-30 | 0000950170-25-106919 | EDGAR | 71K words |
| 2025-05-06 | 2025-03-31 | 0000950170-25-063968 | EDGAR | 68K words |
| 2024-11-12 | 2024-09-30 | 0000950170-24-124575 | EDGAR | 69K words |
| 2024-08-12 | 2024-06-30 | 0000950170-24-095066 | EDGAR | 69K words |
| 2024-05-13 | 2024-03-31 | 0000950170-24-058198 | EDGAR | 67K words |
| 2023-11-09 | 2023-09-30 | 0000950170-23-061533 | EDGAR | 70K words |
| 2023-08-10 | 2023-06-30 | 0000950170-23-040961 | EDGAR | 69K words |
| 2023-05-10 | 2023-03-31 | 0000950170-23-020087 | EDGAR | 67K words |
| 2022-11-09 | 2022-09-30 | 0000950170-22-023507 | EDGAR | 70K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-11-12 | 0001193125-26-456865 | EDGAR | 2K words |
| 2026-10-16 | 0001193125-26-424198 | EDGAR | 1K words |
| 2026-09-30 | 0001193125-26-409199 | EDGAR | 1K words |
| 2026-09-11 | 0001193125-26-388631 | EDGAR | 1K words |
| 2026-09-02 | 0001193125-26-379343 | EDGAR | 3K words |
| 2026-08-18 | 0001193125-26-355664 | EDGAR | 1K words |
| 2026-08-12 | 0001193125-26-345732 | EDGAR | 2K words |
| 2026-04-02 | 0001193125-26-138973 | EDGAR | 1K words |
| 2026-03-04 | 0001193125-26-089871 | EDGAR | 3K words |
| 2026-01-12 | 0001193125-26-009771 | EDGAR | 4K words |
107 total filings indexed. 80 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001783328 |
| Ticker | TCRX |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.tscan.com |
| Listed | 2021-07-16 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/TCRX (~200 tokens, structured JSON with cryptographic provenance)